Core One Labs Inc
Core One Labs Inc. operates as a psychedelic research and development company. The company focuses on providing psychedelic medicines to novel delivery systems and psychedelic assisted psychotherapy; and intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. It also provides natural health products; news dissemination services; financing services; and op… Read more
Core One Labs Inc (CLABF) - Total Liabilities
Latest total liabilities as of December 2023: $1.76 Million USD
Based on the latest financial reports, Core One Labs Inc (CLABF) has total liabilities worth $1.76 Million USD as of December 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Core One Labs Inc - Total Liabilities Trend (2012–2023)
This chart illustrates how Core One Labs Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Core One Labs Inc Competitors by Total Liabilities
The table below lists competitors of Core One Labs Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
POU SHENG INTL
BE:P5C
|
Germany | €4.65 Billion |
|
Cybergun SA
PA:ALCYB
|
France | €39.23 Million |
|
Werth Holz SA
WAR:WHH
|
Poland | zł23.31 Million |
|
MATSA RESOURCES - Dusseldorf Stock Exchang
DU:KB2
|
Germany | €10.21 Million |
|
Xtreme One Entertainment, Inc.
PINK:XONI
|
USA | $2.43 Million |
|
Strip Tinning Holdings PLC
LSE:STG
|
UK | GBX9.53 Million |
Liability Composition Analysis (2012–2023)
This chart breaks down Core One Labs Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.25 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.31 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Core One Labs Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Core One Labs Inc (2012–2023)
The table below shows the annual total liabilities of Core One Labs Inc from 2012 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-03-31 | $1.40 Million | -57.65% |
| 2022-03-31 | $3.30 Million | -20.08% |
| 2021-03-31 | $4.13 Million | -66.10% |
| 2020-03-31 | $12.18 Million | +154.79% |
| 2019-03-31 | $4.78 Million | +113.26% |
| 2018-03-31 | $2.24 Million | +784.36% |
| 2017-03-31 | $253.57K | -32.53% |
| 2016-03-31 | $375.82K | -6.42% |
| 2015-03-31 | $401.59K | +23426.01% |
| 2014-03-31 | $1.71K | -92.73% |
| 2013-03-31 | $23.50K | +871.71% |
| 2012-03-31 | $2.42K | -- |